These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7613727)

  • 1. Prospects for use of recombinant BPI in the treatment of gram-negative bacterial infections.
    Elsbach P; Weiss J
    Infect Agents Dis; 1995 Jun; 4(2):102-9. PubMed ID: 7613727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The bactericidal/permeability increasing protein of neutrophils is a potent antibacterial and anti-endotoxin agent in vitro and in vivo.
    Elsbach P; Weiss J; Doerfler M; Shu C; Kohn F; Ammons WS; Kung AH; Meszaros KK; Parent JB
    Prog Clin Biol Res; 1994; 388():41-51. PubMed ID: 7831373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
    Chockalingam A; McKinney CE; Rinaldi M; Zarlenga DS; Bannerman DD
    Vet Microbiol; 2007 Nov; 125(1-2):80-90. PubMed ID: 17560054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide.
    Elsbach P; Weiss J
    Immunobiology; 1993 Apr; 187(3-5):417-29. PubMed ID: 8330906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endotoxin-binding bactericidal/permeability-increasing protein (BPI): a target antigen of autoantibodies.
    Schultz H; Weiss J; Carroll SF; Gross WL
    J Leukoc Biol; 2001 Apr; 69(4):505-12. PubMed ID: 11310835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial proteins of granulocytes differ in interaction with endotoxin. Comparison of bactericidal/permeability-increasing protein, p15s, and defensins.
    Levy O; Ooi CE; Elsbach P; Doerfler ME; Lehrer RI; Weiss J
    J Immunol; 1995 May; 154(10):5403-10. PubMed ID: 7730641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of bactericidal permeability-increasing protein in the treatment of gram-negative pneumonia.
    Kelly CJ; Cech AC; Argenteanu M; Gallagher H; Shou J; Minnard E; Daly JM
    Surgery; 1993 Aug; 114(2):140-6. PubMed ID: 8342120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficient expression of bactericidal/permeability-increasing protein in immunocompromised hosts: translational potential of replacement therapy.
    Palmer CD; Guinan EC; Levy O
    Biochem Soc Trans; 2011 Aug; 39(4):994-9. PubMed ID: 21787336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.
    Weiss J; Elsbach P; Shu C; Castillo J; Grinna L; Horwitz A; Theofan G
    J Clin Invest; 1992 Sep; 90(3):1122-30. PubMed ID: 1522221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From infection to autoimmunity: a new model for induction of ANCA against the bactericidal/permeability increasing protein (BPI).
    Schultz H
    Autoimmun Rev; 2007 Mar; 6(4):223-7. PubMed ID: 17317612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.
    Chockalingam A; Zarlenga DS; Bannerman DD
    Am J Vet Res; 2007 Nov; 68(11):1151-9. PubMed ID: 17975968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antimicrobial peptides/proteins--application to the therapy of sepsis].
    Sawa T; Kurahashi K
    Masui; 1999 Nov; 48(11):1186-93. PubMed ID: 10586550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of bactericidal/permeability-increasing protein (BPI) analogues on retinal neovascularization and retinal pericyte growth.
    Rauniyar RK; Suzuma K; King AL; Aiello LP; King GL
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):503-9. PubMed ID: 11818397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of the bactericidal/permeability-increasing protein.
    Levy O
    Expert Opin Investig Drugs; 2002 Feb; 11(2):159-67. PubMed ID: 11829710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BPI-ANCA of pediatric cystic fibrosis patients can impair BPI-mediated killing of E. coli DH5alpha in vitro.
    Schultz H; Schinke S; Mosler K; Herlyn K; Schuster A; Gross WL
    Pediatr Pulmonol; 2004 Feb; 37(2):158-64. PubMed ID: 14730661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human granulocytes express a 55-kDa lipopolysaccharide-binding protein on the cell surface that is identical to the bactericidal/permeability-increasing protein.
    Weersink AJ; van Kessel KP; van den Tol ME; van Strijp JA; Torensma R; Verhoef J; Elsbach P; Weiss J
    J Immunol; 1993 Jan; 150(1):253-63. PubMed ID: 7678030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study on bactericidal/permeability increasing protein (BPI) as a natural inhibitor of endotoxin].
    Zhou H
    Zhonghua Shao Shang Za Zhi; 2001 Apr; 17(2):102-4. PubMed ID: 11876922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bactericidal/permeability-increasing protein (BPI) and BPI homologs at mucosal sites.
    Canny G; Levy O
    Trends Immunol; 2008 Nov; 29(11):541-7. PubMed ID: 18838299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The bactericidal/permeability-increasing protein (BPI) in antibacterial host defense.
    Elsbach P
    J Leukoc Biol; 1998 Jul; 64(1):14-8. PubMed ID: 9665269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both N- and C-terminal regions of the bioactive N-terminal fragment of the neutrophil granule bactericidal/permeability-increasing protein are required for stability and function.
    Capodici C; Weiss J
    J Immunol; 1996 Jun; 156(12):4789-96. PubMed ID: 8648126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.